Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

226 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Pancreatitis in children.
Werlin SL, Kugathasan S, Frautschy BC. Werlin SL, et al. Among authors: kugathasan s. J Pediatr Gastroenterol Nutr. 2003 Nov;37(5):591-5. doi: 10.1097/00005176-200311000-00017. J Pediatr Gastroenterol Nutr. 2003. PMID: 14581803
OBJECTIVES: To determine the incidence, etiology and outcome of pancreatitis at a regional children's hospital. METHODS: Chart review of all patients with pancreatitis seen during a 6 year period at the Children's Hospital of Wisconsin. ...
OBJECTIVES: To determine the incidence, etiology and outcome of pancreatitis at a regional children's hospital. METHODS: Chart review …
Prolonged duration of response to infliximab in early but not late pediatric Crohn's disease.
Kugathasan S, Werlin SL, Martinez A, Rivera MT, Heikenen JB, Binion DG. Kugathasan S, et al. Am J Gastroenterol. 2000 Nov;95(11):3189-94. doi: 10.1111/j.1572-0241.2000.03263.x. Am J Gastroenterol. 2000. PMID: 11095340 Clinical Trial.
OBJECTIVES: Tumor necrosis factor-alpha plays a central role in chronic intestinal inflammation of Crohn's disease. Targeting this cytokine with the chimeric monoclonal antibody infliximab has emerged as an effective form of therapy in adult Crohn's disease patients …
OBJECTIVES: Tumor necrosis factor-alpha plays a central role in chronic intestinal inflammation of Crohn's disease. Targeting this cy …
Percutaneous colonoscopic cecostomy for management of chronic constipation in children.
Rivera MT, Kugathasan S, Berger W, Werlin SL. Rivera MT, et al. Among authors: kugathasan s. Gastrointest Endosc. 2001 Feb;53(2):225-8. doi: 10.1067/mge.2001.112182. Gastrointest Endosc. 2001. PMID: 11174301
Prolonged duration of response to infliximab in early pediatric Crohn's disease.
Kugathasan S. Kugathasan S. J Pediatr Gastroenterol Nutr. 2001 Sep;33 Suppl 1:S40-3. doi: 10.1097/00005176-200109001-00007. J Pediatr Gastroenterol Nutr. 2001. PMID: 11685975 Clinical Trial. No abstract available.
Ureteropelvic junction obstruction: an overlooked cause of cyclic vomiting.
Schulte-Bockholt A, Kugathasan S, Mesrobian HG, Werlin SL. Schulte-Bockholt A, et al. Among authors: kugathasan s. Am J Gastroenterol. 2002 Apr;97(4):1043-5. doi: 10.1111/j.1572-0241.2002.05626.x. Am J Gastroenterol. 2002. PMID: 12003386
Infliximab retreatment in adults and children with Crohn's disease: risk factors for the development of delayed severe systemic reaction.
Kugathasan S, Levy MB, Saeian K, Vasilopoulos S, Kim JP, Prajapati D, Emmons J, Martinez A, Kelly KJ, Binion DG. Kugathasan S, et al. Am J Gastroenterol. 2002 Jun;97(6):1408-14. doi: 10.1111/j.1572-0241.2002.05784.x. Am J Gastroenterol. 2002. PMID: 12094858
OBJECTIVES: Although effective in the treatment of refractory Crohn's disease, episodic retreatment with the antitumor necrosis factor a chimeric monoclonal antibody infliximab (Remicade, Centocor, Malvern, PA) can be associated with severe acute and delayed systemic react …
OBJECTIVES: Although effective in the treatment of refractory Crohn's disease, episodic retreatment with the antitumor necrosis facto …
Pancreatitis as a presenting manifestation of pediatric Crohn's disease: a report of three cases.
Kugathasan S, Halabi I, Telega G, Werlin SL. Kugathasan S, et al. J Pediatr Gastroenterol Nutr. 2002 Jul;35(1):96-8. doi: 10.1097/00005176-200207000-00022. J Pediatr Gastroenterol Nutr. 2002. PMID: 12142820 No abstract available.
Dermatologic manifestations of Crohn disease in children: response to infliximab.
Kugathasan S, Miranda A, Nocton J, Drolet BA, Raasch C, Binion DG. Kugathasan S, et al. J Pediatr Gastroenterol Nutr. 2003 Aug;37(2):150-4. doi: 10.1097/00005176-200308000-00013. J Pediatr Gastroenterol Nutr. 2003. PMID: 12883301
Epidemiologic and clinical characteristics of children with newly diagnosed inflammatory bowel disease in Wisconsin: a statewide population-based study.
Kugathasan S, Judd RH, Hoffmann RG, Heikenen J, Telega G, Khan F, Weisdorf-Schindele S, San Pablo W Jr, Perrault J, Park R, Yaffe M, Brown C, Rivera-Bennett MT, Halabi I, Martinez A, Blank E, Werlin SL, Rudolph CD, Binion DG; Wisconsin Pediatric Inflammatory Bowel Disease Alliance. Kugathasan S, et al. J Pediatr. 2003 Oct;143(4):525-31. doi: 10.1067/s0022-3476(03)00444-x. J Pediatr. 2003. PMID: 14571234
RESULTS: The incidence of IBD in Wisconsin children was 7.05 per 100,000, whereas the incidence for Crohn's disease was 4.56, more than twice the rate of ulcerative colitis (2.14). ...The surprisingly high incidence of pediatric IBD, the predominance of Crohn's dise …
RESULTS: The incidence of IBD in Wisconsin children was 7.05 per 100,000, whereas the incidence for Crohn's disease was 4.56, more th …
Comparative phenotypic and CARD15 mutational analysis among African American, Hispanic, and White children with Crohn's disease.
Kugathasan S, Loizides A, Babusukumar U, McGuire E, Wang T, Hooper P, Nebel J, Kofman G, Noel R, Broeckel U, Tolia V. Kugathasan S, et al. Inflamm Bowel Dis. 2005 Jul;11(7):631-8. doi: 10.1097/01.mib.0000171279.05471.21. Inflamm Bowel Dis. 2005. PMID: 15973116
BACKGROUND: Despite a large body of literature on the subject of Crohn's disease (CD), very little information is available on racial/ethnic differences related to disease presentation, clinical course, and genetics. ...
BACKGROUND: Despite a large body of literature on the subject of Crohn's disease (CD), very little information is available on racial …
226 results
Jump to page
Feedback